Transcription of Cardiac Biomarkers - Open
{{id}} {{{paragraph}}}
Example: dental hygienist
Cardiac Biomarkers - Open
2 Cardiac Biomarkers Sadip Pant1, Abhishek Deshmukh1, Pritam Neupane2, Kavin Kumar3 and Vijayashankar4 1 University of Arkansas For Medical Sciences, Little Rock, AR 2 Medical College of Georgia, Augusta, GA 3 Department of Internal Medicine, Priya Hospital-Heart and Diabetic Care Tamilnadu 4 Apollo Hospitals Greams Road, Chennai, Tamilnadu 1,2 USA 3,4 India 1. Introduction 1950 s: Clinical reports that transaminases released from dying myocytes could be detected via laboratory testing, aiding in the diagnosis of myocardial infarction. The race to define clinical markers to aid in the diagnosis, prognosis, and risk stratification of patients with potential cardiovascular disease begins. Initial serum markers included AST, LDH, total CK and -hydroxybutyrate. These enzymes are all released in varying amounts by dying myocytes.
Cardiac markers are used in the diagnosis and risk stratification of patients with chest pain and suspected acute coronary syndrome (ACS). The cardiac troponins, in particular, have
Loading..
Tags:
Information
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
Related search queries
Cardiac Markers, Patients suspected of acute myocardial infarction, The Use of Biochemical Cardiac Markers, Strategic Utilization of Cardiac Markers, Order Form Back, MATERIAL SAFETY, MYOCARDIAL INFARCTION, Cardiac, Chemistry Product Groups, Cardiac Assessment Controls, Cardiac Biomarkers for Better Management, Cardiac Biomarkers for Better Management of Acute Coronary Syndromes, Markers